Temporal course of late rectal toxicity & impact of intervention in patients undergoing radiation for cervical cancer
Open Access
- 1 January 2021
- journal article
- research article
- Published by Medknow in Indian Journal of Medical Research
- Vol. 154 (2), 375-382
- https://doi.org/10.4103/ijmr.ijmr_4787_20
Abstract
Background & objectives: There is limited information available on the temporal course of late stage radiotherapy adverse effects. The present study reports on the temporal course of late toxicities after chemoradiation and brachytherapy. Methods: Women with cervical cancer who presented with late toxicity after (chemo) radiation were included in the study. Grade of toxicity (Clinical Toxicity Criteria for Adverse Events version 4.03) and type of intervention were recorded at three-monthly interval for the first year and then six monthly until 24 months. Direct cost for the management of toxicity was calculated. Univariate analysis was performed to understand the impact of various factors on persistence of toxicity. Results: Ninety two patients were included in this study. Grades I, II, III and IV toxicities were observed in 50 (54%), 33 (36%), 7 (8%) and 2 (2%) patients, respectively, at first reporting. Patients spent a median of 12 (3-27) months with toxicity. At 12 months, 48/92 (52.2%) patients had a complete resolution of toxicity, whereas 27/92 (29.3%) patients had low grade (I-II) persistent toxicity. Only 6/92 (6.5%) patients who had grade III-IV toxicity had resolution to a lower grade. Four (4.3%) patients died due to toxicity. At 24 months, 9 (10%) patients continued to have grade = III toxicity. On an average, 7 (2-24) interventions were required for the clinical management of late toxicity and median direct cost incurred was. 50,625 (1,125-303,750). Interpretation & conclusions: In this study late radiation toxicity resolved within 12 months in more than half of patients. However, others are likely to have had persistent lower grade toxicity or progression to higher grade. Structured strategies are hence needed for the effective management of late toxicities.This publication has 20 references indexed in Scilit:
- Late rectal toxicity after image-based high-dose-rate interstitial brachytherapy for postoperative recurrent and/or residual cervical cancers: EQD2 predictors for Grade ≥II toxicityBrachytherapy, 2015
- Is argon plasma coagulation an effective and safe treatment option for patients with chronic radiation proctitis after high doses of radiotherapy?2014
- Time course of late rectal- and urinary bladder side effects after MRI-guided adaptive brachytherapy for cervical cancerStrahlentherapie und Onkologie, 2013
- Evaluation of Interobserver and Interscale Agreement in Assessing Late Bowel Toxicity after Pelvic Radiation in Patients with Carcinoma of the CervixJapanese Journal of Clinical Oncology, 2013
- Argon plasma coagulation has a long-lasting therapeutic effect in patients with chronic radiation proctitisEndoscopy, 2009
- Hyperbaric Oxygen Treatment of Chronic Refractory Radiation Proctitis: A Randomized and Controlled Double-Blind Crossover Trial With Long-Term Follow-UpEndocrine, 2008
- TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology GroupThe Lancet Oncology, 2007
- A Randomized Trial of Pelvic Radiation Therapy versus No Further Therapy in Selected Patients with Stage IB Carcinoma of the Cervix after Radical Hysterectomy and Pelvic Lymphadenectomy: A Gynecologic Oncology Group StudyGynecologic Oncology, 1999
- Cisplatin, Radiation, and Adjuvant Hysterectomy Compared with Radiation and Adjuvant Hysterectomy for Bulky Stage IB Cervical CarcinomaThe New England Journal of Medicine, 1999
- Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancerThe Lancet, 1997